About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Vulnerability to Ebola and Lassa Fever can Now be Properly Assessed, Says Research

by Colleen Fleiss on June 5, 2019 at 7:11 PM
Font : A-A+

Vulnerability to Ebola and Lassa Fever can Now be Properly Assessed, Says Research

Identifying vulnerabilities to Ebola and Lassa fever outbreaks is now possible, revealed research from the University of Surrey and University of Cambridge. This will aid government agencies and health organisations in evaluating a country's vulnerability to outbreaks, and inform decisions on strategic investments and plans.

Vulnerability - an assessment of a country's ability or inability to resist a hazard or to respond when a disaster has occurred - is a well-established model in the field of climate change and natural disasters; however, in disease management it is a relatively undefined concept. To assess this kind of vulnerability researchers developed a new methodology that - instead of focussing on the confirmed number of patients infected with the disease (impact) - monitors the number of survivors ('adaptive capacity'). A simple mathematical formula of impact versus adaptive capacity has been used to calculate a degree of vulnerability, which will help international bodies allocate resources.

Advertisement


To test their model researchers examined data from Lassa fever epidemics in Nigeria (2017 - 2018) and Sierra Leone (2008 - 2012) and Ebola in Sierra Leone (2013 - 2016). Using the methodology, researchers found that the most vulnerable states are not necessarily those with the highest number of confirmed cases; for instance, the state of Plateau in Nigeria was found to be the most vulnerable to Lassa fever despite the relatively low burden of the disease in the region.

Researchers also found that vulnerability can change during an outbreak. The vulnerability to Lassa fever in Nigeria decreased during of epidemics compared to the vulnerability for Sierra Leone that increased after 2010, indicating a rising number of deaths. The data available suggests a difficulty in coping with the disease in the region.
Advertisement

The next step is to investigate how vulnerability depends on relevant environmental and socio-economic indicators, for example health expenditure, which might suggest practical approaches for the reduction of vulnerability.

Dr Gianni Lo Iacono, Lecturer in Biostatistics and Epidemiology at the School of Veterinary Science at the University of Surrey, said: "The increasing danger of zoonotic diseases, such as Ebola and Lassa fever, has led to an urgent need to develop techniques to help public health practitioners evaluate how vulnerable populations are to epidemics.

Source: Eurekalert
Advertisement

Advertisement

Recommended Reading

Latest Tropical Disease News

Hope for Pregnant Women: New Malaria Study Offers Optimistic News
Pregnant women in Korogwe, Tanzania are found to have a high risk of contracting malaria, which is one of the deadliest diseases in sub-Saharan Africa.
Nasal Swab can Help Detect Early Warning of Emerging Viruses
Can nasal swab test save you from emerging diseases? Yes, simple nasal swab can offer early detection of new deadly viruses.
<i>Naegleria Fowleri</i> Infection: Deadly Brain-Eating Amoeba Kills a South Korean Man
Brain-eating amoeba (Naegleria fowleri) infection claims a South Korean man's life.
Infrared Light Beam to Detect Malaria
Harmless infrared light is used to detect malaria with the help of a computer algorithm processed by a smart phone.
Monkeypox Virus in Testes of Non-human Primate Survivors Detected
Monkeypox virus may be shed into semen during both acute and convalescent stages of the disease in crab-eating macaques.
View All
open close
CONSULT ONLINE WITH A DOCTOR

×

Vulnerability to Ebola and Lassa Fever can Now be Properly Assessed, Says Research Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests